| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +1.25K | 100% | $20.03 | +$25K |
| Sells | 0 | ||||
| Net | +1 | +1.25K | 100% | +$25K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Michael A. Metzger | Chief Executive Officer, Director | $7.63M | Feb 7, 2024 | ||
| Steve M. Sabus | Chief Commercial Officer | $5.69M | Dec 5, 2022 | ||
| Catherine Madigan | Chief Medical Officer | $2.84M | Feb 2, 2023 | ||
| Keith A. Goldan | Chief Financial Officer | $2.61M | +$25K | +0.97% | Jun 14, 2024 |
| Dennis Podlesak | Director | $2.59M | Feb 7, 2024 | ||
| Neil Gallagher | President, Head of R&D | $2.42M | Feb 7, 2024 | ||
| William Meury | Director | $1.19M | Feb 7, 2024 | ||
| Keith Katkin | Director | $1.19M | Feb 7, 2024 | ||
| Jennifer Jarrett | Director | $1.19M | Feb 7, 2024 | ||
| Pierre Legault | Director | $1.19M | Feb 7, 2024 | ||
| Martin H. Huber Jr. | Director | $895K | Feb 7, 2024 | ||
| Michael L. Meyers | SVP, Chief Medical Officer | $874K | Feb 2, 2022 | ||
| Aleksandra Rizo | Director | $780K | May 15, 2024 | ||
| Briggs Morrison | Director | $636K | Feb 7, 2024 | ||
| Fabrice Egros | Director | $584K | Feb 2, 2022 | ||
| Alexander Nolte | Chief Accounting Officer | $439K | Feb 2, 2023 | ||
| Peter Ordentlich | Chief Scientific Officer | Feb 15, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|